| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $27.7M | +48.4% |
| SG&A Expense | $12.8M | +10.8% |
| Operating Income | -$44.9M | -23.6% |
| Interest Expense | $154K | +88.2% |
| Income Tax | $0 | — |
| Net Income | -$44.9M | -23.6% |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $44.1M | +25.1% |
| Current Assets | $52.1M | +38.7% |
| Total Assets | $59.2M | +36.4% |
| Current Liabilities | $9.8M | +8.7% |
| Long-term Debt | $3.6M | +35.2% |
| Total Liabilities | $13.2M | +25.0% |
| Stockholders' Equity | $46.0M | +40.1% |
| Line Item | 2022-02-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.0M | -91.1% |
| Capital Expenditures | $4.8M | +177.6% |
| Investing Cash Flow | -$5.1M | -71.7% |
| Financing Cash Flow | $57.0M | +114.3% |
| Free Cash Flow | -$47.8M | -97.3% |